Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
PLoS Med. 2013;10(7):e1001478. doi: 10.1371/journal.pmed.1001478. Epub 2013 Jul 2.
A multicenter study was conducted to evaluate the diagnostic accuracy (sensitivity and specificity) of the Verigene Gram-Positive Blood Culture Test (BC-GP) test to identify 12 Gram-positive bacterial gene targets and three genetic resistance determinants directly from positive blood culture broths containing Gram-positive bacteria.
1,252 blood cultures containing Gram-positive bacteria were prospectively collected and tested at five clinical centers between April, 2011 and January, 2012. An additional 387 contrived blood cultures containing uncommon targets (e.g., Listeria spp., S. lugdunensis, vanB-positive Enterococci) were included to fully evaluate the performance of the BC-GP test. Sensitivity and specificity for the 12 specific genus or species targets identified by the BC-GP test ranged from 92.6%-100% and 95.4%-100%, respectively. Identification of the mecA gene in 599 cultures containing S. aureus or S. epidermidis was 98.6% sensitive and 94.3% specific compared to cefoxitin disk method. Identification of the vanA gene in 81 cultures containing Enterococcus faecium or E. faecalis was 100% sensitive and specific. Approximately 7.5% (87/1,157) of single-organism cultures contained Gram-positive bacteria not present on the BC-GP test panel. In 95 cultures containing multiple organisms the BC-GP test was in 71.6% (68/95) agreement with culture results. Retrospective analysis of 107 separate blood cultures demonstrated that identification of methicillin resistant S. aureus and vancomycin resistant Enterococcus spp. was completed an average of 41.8 to 42.4 h earlier using the BC-GP test compared to routine culture methods. The BC-GP test was unable to assign mecA to a specific organism in cultures containing more than one Staphylococcus isolate and does not identify common blood culture contaminants such as Micrococcus, Corynebacterium, and Bacillus.
The BC-GP test is a multiplex test capable of detecting most leading causes of Gram-positive bacterial blood stream infections as well as genetic markers of methicillin and vancomycin resistance directly from positive blood cultures.
一项多中心研究评估了 Verigene 革兰阳性菌血培养检测(BC-GP)试验鉴定 12 种革兰阳性菌靶基因和 3 种遗传耐药决定因素的诊断准确性(灵敏度和特异性),该试验可直接从含有革兰阳性菌的阳性血培养物中检测。
2011 年 4 月至 2012 年 1 月,在五个临床中心前瞻性采集并检测了 1252 份含有革兰阳性菌的血培养物。为了全面评估 BC-GP 试验的性能,还包括了 387 份含有不常见靶标(例如李斯特菌属、S. lugdunensis、vanB 阳性肠球菌)的人工血培养物。BC-GP 试验鉴定的 12 种特定属或种靶基因的灵敏度和特异性分别为 92.6%-100%和 95.4%-100%。在 599 份含有金黄色葡萄球菌或表皮葡萄球菌的培养物中,mecA 基因的鉴定敏感性为 98.6%,特异性为 94.3%,与头孢西丁纸片法相比。在 81 份含有粪肠球菌或屎肠球菌的培养物中,vanA 基因的鉴定敏感性和特异性均为 100%。约 7.5%(87/1157)的单种菌培养物含有 BC-GP 试验板上未检测到的革兰阳性菌。在 95 份含有多种菌的培养物中,BC-GP 试验与培养结果的符合率为 71.6%(68/95)。对 107 份单独血培养物的回顾性分析显示,与常规培养方法相比,使用 BC-GP 试验鉴定耐甲氧西林金黄色葡萄球菌和万古霉素耐药肠球菌的时间平均提前了 41.8-42.4 小时。BC-GP 试验无法将 mecA 分配给含有多个葡萄球菌分离株的培养物中的特定菌,并且不能识别常见的血培养物污染物,如微球菌、棒状杆菌和芽孢杆菌。
BC-GP 试验是一种多重检测试验,能够直接从阳性血培养物中检测出引起革兰阳性菌血流感染的大多数主要病原体以及耐甲氧西林和万古霉素的遗传标记物。